eStar Update: Expansion of PREDICT program

The PREDICT (Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment), a genomic laboratory panel test that supports providers with information about how their patients may respond to different medicines, was recently updated with five (5) SSRIs and an antiemetic. This update brings the total in the PREDICT arsenal to 16 drug-gene-interactions. (For a complete list, please visit: https://www.mydruggenome.org/dgi/)

Providers and patients may have received communications about these efforts through eStar and My Health at Vanderbilt. Regardless of the changes, there is no new testing, and no charges to patients – only extension of the previous results to support the prescribing of additional drugs. By revisiting historical results against the current, expanded framework, the PREDICT program has enabled the most complete suite of clinical decision support to help guide prescribing.

Further support for the use of these results for patient care is available through e-consults by pharmacogenomics pharmacist, Michelle Liu (michelle.liu.1@vumc.org). In addition, outpatient consults are available through the VUMC Genomics and Therapeutics Clinic to help advise pharmacogenomic testing and interpretation (GATC@vumc.org). For general questions about the PREDICT program, contact PREDICT@vumc.org .